High-fat ketogenic diet ‘can help treat persistent childhood seizures’

Washington, May 18 (ANI): A high-fat ketogenic diet, made up of high-fat foods and few carbohydrates, can help reduce or completely eliminate debilitating seizures in most children with infantile spasms, whose seizures persist despite medication, say researchers.

The Johns Hopkins Children”s Center study has been published online April 30 in the journal Epilepsia.

Infantile spasms, also called West syndrome, is a stubborn form of epilepsy that often does not get better with antiseizure drugs. Because poorly controlled infantile spasms may cause brain damage, the Hopkins team”s findings suggest the diet should be started at the earliest sign that medications aren”t working.

“Stopping or reducing the number of seizures can go a long way toward preserving neurological function, and the ketogenic diet should be our immediate next line of defense in children with persistent infantile spasms who don”t improve with medication,” says senior investigator Eric Kossoff, M.D., a pediatric neurologist and director of the ketogenic diet program at Hopkins Children”s.

The ketogenic diet works by triggering biochemical changes that eliminate seizure-causing short circuits in the brain”s signaling system. It has been used successfully in several forms of epilepsy. (ANI)

Watching 3D TV can cause nausea

London, April 17 (ANI): Watching 3D films can cause nausea, according to a new health warning.

According to the warning, a 3D TV can cause people to suffer from vomiting and cramps.

Pregnant women, elders and children are the ones to suffer the most from the use of 3D TVs.

The notice, issued by Electronic giant Samsung, has also warned that 3D TV may cause fits in people suffering from epilepsy, reports The Daily Star.

Watching a 3D TV puts “unusual strain” on the body and it drastically disturbs the eyes and the brain with flashy images, says the report. (ANI)

First direct recording of mirror neurons in human brain

Washington, Apr 17 (ANI): For the first time, researchers have made a direct recording of mirror neurons in the human brain.

It is believed that mirror neurons are what make us human-they are the cells in the brain that fire not only when we perform a particular action but also when we watch someone else perform that same action.

Neuroscientists have said that this “mirroring” is the mechanism by which we can “read” the minds of others and empathize with them. It”s how we “feel” someone”s pain, how we discern a grimace from a grin, a smirk from a smile.

But, until now, there was no proof that mirror neurons existed – only suspicion and indirect evidence.

Dr. Itzhak Fried, a UCLA professor of neurosurgery and of psychiatry and biobehavioural sciences, Roy Mukamel, a postdoctoral fellow in Fried”s lab, and their colleagues have recorded both single cells and multiple-cell activity, not only in motor regions of the brain where mirror neurons were thought to exist but also in regions involved in vision and in memory.

They also showed that specific subsets of mirror cells increased their activity during the execution of an action but decreased their activity when an action was only being observed.

“We hypothesize that the decreased activity from the cells when observing an action may be to inhibit the observer from automatically performing that same action. Furthermore, this subset of mirror neurons may help us distinguish the actions of other people from our own actions,” said Mukamel.

The researchers drew their data directly from the brains of 21 patients who were being treated at Ronald Reagan UCLA Medical Center for intractable epilepsy.

The patients had been implanted with intracranial depth electrodes to identify seizure foci for potential surgical treatment.

Electrode location was based solely on clinical criteria; the researchers, with the patients” consent, used the same electrodes to “piggyback” their research.

The researchers found that the neurons fired or showed their greatest activity both when the individual performed a task and when they observed a task.

The mirror neurons making the responses were located in the medial frontal cortex and medial temporal cortex, two neural systems where mirroring responses at the single-cell level had not been previously recorded, not even in monkeys.

This new finding demonstrates that mirror neurons are located in more areas of the human brain than previously thought.

Given that different brain areas implement different functions – in this case, the medial frontal cortex for movement selection and the medial temporal cortex for memory – the finding also suggests that mirror neurons provide a complex and rich mirroring of the actions of other people.

Because mirror neurons fire both when an individual performs an action and when one watches another individual perform that same action, it is believed that this “mirroring” is the neural mechanism by which the actions, intentions and emotions of other people can be automatically understood.

“The study suggests that the distribution of these unique cells linking the activity of the self with that of others is wider than previously believed,” said Fried.

“It”s also suspected that dysfunction of these mirror cells might be involved in disorders such as autism, where the clinical signs can include difficulties with verbal and nonverbal communication, imitation and having empathy for others. So gaining a better understanding of the mirror neuron system might help devise strategies for treatment of this disorder,” said Mukamel.

The study was published in the latest edition of the journal Current Biology. (ANI)

Malaysian-Indian woman’s widower wins racism battle against Hong Kong hospital

London, Apr. 1 (ANI): The husband of a Malaysian-Indian woman, who died in 2000 due to the negligence of a Hong Kong hospital’s staff, has finally won the legal battle of racial discrimination against the hospital administration.

Martin Jacques, a journalist, has been awarded with a “substantial sum” in compensation after winning the decade old battle.

“No one can compensate for Hari”s (Harinder Veriah) death but justice does matter. It is tragic that care for those who are ill can be prejudiced by their colour. But as Hari found in 14 months in Hong Kong, racism is endemic to Hong Kong society,” The Guardian quoted Jacques, as saying.

Veriah died in the Ruttonjee Hospital on January 2, 2000 after an epileptic seizure.

A day before her death, she had complained to Jacques about her poor treatment, saying she was at the “bottom of the pile” because of the colour of her skin.

“I fought to get hospital records and I started to get a picture of what happened and the picture was that her treatment was outrageous. There”s absolutely no reason why someone should die from epilepsy,” Jacques said.

Veriah, a lawyer, was admitted to Ruttonjee Hospital after suffering a grand mal epileptic fit on the first day of the millennium, after a celebratory night out.

When he received a call from a nurse the next morning to say that Veriah had suffered another fit, he was at her bedside within 10 minutes.

There was no sign of a doctor, who had prescribed Valium, he said. Veriah never regained consciousness and died shortly afterwards.

Jacques later found out that t Veriah had suffered a respiratory depression – a decline in oxygen – after being given a sedative and that she was not monitored or treated properly. (ANI)

Messenger banned from Parliament precinct for heckling

Queensland Health Minister Paul Lucas has criticised Opposition MP Rob Messenger for getting kicked out of State Parliament today, but also agreed to help his constituent.

While Mr Lucas was speaking about epilepsy awareness, Mr Messenger, the Member for Burnett, repeatedly interjected.

He says a doctor at the Bundaberg Hospital misdiagnosed a miscarriage and the woman should have private treatment.

“I will do anything to ensure that that couple are given enough medical care,” he said.

Mr Messenger was ejected and banned from the Parliamentary precinct for a week.

Mr Lucas says Mr Messenger did not make it to Question Time.

“His conduct excluded him from Parliament today denying him the opportunity to ask questions he saw as important to his electorate,” he said.

Mr Lucas says the woman will receive the best medical treatment including private care.

Opposition Leader John-Paul Langbroek says Mr Messenger was speaking on behalf of his constituents.

“Obviously Rob is very, very passionate about the issues that have affected Bundaberg in the past,” he said.

“We’re all aware of those and today once again with another issue in Bundaberg that he’s prosecuting, his passion came out again.”

Chinese man kills boy, 11, eats his brain of to cure epilepsy

London, March 19 (ANI): In a shocking case, a Chinese man allegedly killed an 11-year-old boy and ate his brain, believing it would cure his epilepsy.

A superstitious man, Wang Chaoxu, of Qixian village, Yunnan, allegedly murdered Li Xuetang, whose dead body has been found buried in a grain field in a neighboring hamlet.

The victim’s head was peeled back and part of his brain was removed.

Chaoxu was arrested after a villager Zhang Huansheng found him kneeling over the corpse.

Chaoxu told police he believed eating the brain with earthworms and ants would cure his illness.

He was apparently married to a nurse, who left him because of his illness.

Xuetang’s mourning mother Yu Chaohu said that her son had disappeared late at night.

“It was getting dark, but I couldn”t find my son anywhere in the village,’ the Sun quoted her as saying.

She added: “I even asked the village head to broadcast on the radio to ask my son to come back home for dinner.”

Chaohu was stopped from looking at her son’s body, as it was too damaged.

She added: “I can”t bear to think about what happened to him. I have nightmares thinking about it.”

Police are investigating that Chaoxu might have also killed a three-year-old girl, who went missing the same day and was later found dead in a public toilet with her head split. (ANI)

Australian court favours release of teenage duo who attacked Indians

MELBOURNE: An Australian court today favoured release of two teenage brothers, who spent less than a year in youth detention for racially assaulting a group of Indians, even as it termed the attack which left one of the victims with permanent brain injuries as “extraordinarily grave”.

Victorian County Court judge Christine Thornton said that because the two, aged 17 and 18, were “children” she should indicate that they would not be locked up again for the December 2008 incident, according to AAP.

However, Thornton described the assault as “extraordinarily grave”.

The re-sentencing of the two boys, who served less than a year in youth detention, is set to take place shortly after Director of Public Prosecution (DPP) appealed against their sentences.

As per the appeal system, Thornton is required to re-sentence the duo, even if she does not increase their jail terms, the report said.

The two brothers carried out an unprovoked attack in an Indian convenience store in Sunshine, where eight men were injured, including one who spent 15 days in coma and was left with permanent brain injuries.

Chief Crown prosecutor Gavin Silbert SC told the court that the older youth smashed 27-year old Sukhraj Singh with a piece of wood, leaving him unconscious and bleeding with multiple skull and face fractures.

Singh had been told his injuries were permanent and there was a chance he would suffer from epilepsy.

Soon, robot controlled by human brain cells

London, Sept 10 (ANI): Scientists from University of Reading are working on developing a robot that would be controlled by human brain cells.

Lead researchers Kevin Warwick and Ben Whalley have already used rat brain cells to control a simple wheeled robot.

During the study, the researchers grew around 300,000 rat neurons in a nutrient broth and device producing spikes of electrical activity were connected to the output of the robot’s distance sensors.

The neurons could successfully steer the robot around a small enclosure.

Based on the findings rat models, the researchers are now working on steering the robot with the help of human brain cells.

The researchers believe that understanding how the neuron culture responds to stimulation could lead to deeper insights of neurological conditions such as epilepsy.

For instance, the way large numbers of neurons sometimes spike in unison – a phenomenon known as “bursting” – may be similar to what happens during an epileptic seizure.

The research team suggests if the behavior could be altered by changing the culture chemically, electrically or physically, it might pave way for potential therapies.

To make the system a better model of human disease, a culture of human neurons will be connected to the robot once the current work with rat cells is completed.

They will analyze the differences in the behavior of robots controlled by rat and human neurons.

“We’ll be trying to find out if the learning aspects and memory appear to be similar,” New Scientist quoted Warwick as saying. (ANI)

Single gene mutation behind catastrophic epilepsy

Washington, July 8 (ANI): Researchers at Baylor College of Medicine have found a mutation in a single gene to be responsible for catastrophic epilepsy – characterized by severe muscle spasms, persistent seizures, mental retardation and sometimes autism.

Dr. Jeffrey Noebels, professor of neurology, neuroscience and molecular and human genetics at BCM and director of the Blue Bird Circle Developmental Neurogenetics Laboratory at BCM, said that the team replicated the defect in mice, developing a mouse model of the disease that could help researchers figure out effective treatments for and new approaches to curing the disease.

“While many genes underlying various forms of childhood epilepsy have been identified in the past decade, most cause a disorder of ‘pure’ seizures,” said Noebels.

Why some children have a more complicated set of disorders beginning with major motor spasms in infancy followed by cognitive dysfunction and developmental disorders such as autism remained a mystery until the discovery by the BCM team that a mutation in only a single gene explains all four features of catastrophic epilepsy.

A gene known as Aristaless-related homeobox or ARX has a specific mutation called a triplet repeat, which means that a particular genetic (in this case, GCG) is repeated many times in the gene.

When the researchers duplicated this particular mutation in specially bred mice, the animals had motor spasm similar to those seen in human infants.

Recordings of their brain waves showed that they had several kinds of seizes, included absence epilepsy and general convulsion. They also had learning disabilities and were four times more likely to avoid contact with other mice than their normal counterparts.

This behaviour is similar to that seen in children with autism or similar disorders in the same spectrum.

“The new model is an essential tool to find a cure for the disorder,” said Noebels.

The study appears in the current issue of the Journal of Neuroscience. (ANI)

Brain’s immune system may cause chronic seizures

Washington, July 7 (ANI): A new study has revealed that chronic seizures caused by traumatic head injuries might occur due to chemicals released by the brain’s immune system attempting to repair the injured site.

Researchers from University of Colorado at Boulder have revealed that micro-glial cells may play a major role in seizures.

They found that glial cells, which are supportive cells that also constitute a major part of the brain’s immune system, cluster within areas in the brain when a severe brain injury has occurred.

“When there has been serious damage to the brain, such as a head injury or infection, the immune system is activated and tries to counteract the damage and repair it,” said CU-Boulder psychology and neuroscience Professor Daniel Barth.

“These glial cells migrate to the damaged area and release chemicals called cytokines that, unfortunately, also profoundly increase the excitability of the neurons that they are near.

“In our new study, we showed for the first time that glial cells moving in and secreting these cytokines cause the neurons in the area to become excitable enough to cause seizures,” he added.

Barth hopes that the findings may help prevent one of the most common forms of adult epilepsy, called acquired epilepsy, which is often found in people who have suffered a brain injury or infection.

He said if the brain’s initial immunity reaction could be temporarily shut down, this could prevent the development of acquired epilepsy.

“So instead of giving anti-seizure drugs, which have no effect in preventing or subsequently treating post-traumatic epilepsy, we could give some anti-immune drugs which may actually stop the process of developing epilepsy in the first place,” Barth added.

The study appears in the journal Brain. (ANI)

Locusts’ brains may provide clues to curing migraines, stroke

Washington, July 4 (ANI): Queen’s University biologists have revealed that insight into the locust’s brain may offer a novel way to manipulate human brain to stave off diseases like migraines, stroke, and epilepsy.

The researchers said that a similarity in brain disturbance between the insect and human sufferers of migraines, stroke, and epilepsy could open pathways for development of new drug therapies.

The study showed that the ability of the insect to resist entering the coma, and the speed of its recovery, can be manipulated using drugs that target one of the cellular signalling pathways in the brain.

“This suggests that similar treatments in humans might be able to modify the thresholds or severity of migraine and stroke,” said Gary Armstrong, who is completing his PhD research in Biology professor Mel Robertson’s laboratory.

“What particularly excites me is that in one of our locust models, inhibition of the targeted pathway completely suppresses the brain disturbance in 70 per cent of animals,” Dr. Robertson added.

The same researchers previously showed that locusts go into a coma as a way of shutting down and conserving energy, when conditions are dangerous.

The cellular responses in the locust are similar to the response of brain cells at the onset of a migraine. (ANI)

Scientists identify alcohol-binding site in the brain

London, June 29 (ANI): Scientists at the Salk Institute for Biological Studies have a step closer to understanding how alcohol alters the way brain cells work.

The researchers say that they have identified a binding site for alcohol in an ion channel that plays a key role in several brain functions associated with drugs of abuse and seizures.

They believe that their results could lead to the development of novel treatments for alcoholism, drug addiction, and epilepsy.

Ethanol, the alcohol in intoxicating beverages, is known to alter the communication between brain cells.

“There’s been a lot of interest in the field to find out how alcohol acts in the brain,” Nature magazine quoted Dr. Paul A. Slesinger, an associate professor in the Peptide Biology Laboratory at the Salk Institute, as saying.

“One of several views held that ethanol works by interacting directly with ion channel proteins, but there were no studies that visualized the site of association,” added the lead researcher.

He says that his study has shown that alcohols directly interact with a specific nook contained within a channel protein.

According to him, this ion channel plays a key role in several brain functions associated with drugs of abuse and seizures.

In their previous research, Slesinger’s team focused on the neural function of these ion channels, called GIRK channels, which open up during periods of chemical communication between neurons and dampen the signal, creating the equivalent of a short circuit.

“When GIRKs open in response to neurotransmitter activation, potassium ions leak out of the neuron, decreasing neuronal activity,” says UCSD Biology graduate student and first author Prafulla Aryal.

While alcohols have been previously shown to open up GIRK channels, no study ever determined whether this was a direct effect or whether this was the by-product of other molecular changes in the cell.

The researchers say that the identification of the location of a physical alcohol-binding site important for GIRK channel activation could point to new strategies for treating related brain diseases.

They believe that this protein structure may be used to develop a drug that antagonizes the actions of alcohol for the treatment of alcohol dependence.

“(Alternatively) If we could find a novel drug that fits the alcohol-binding site and then activate GIRK channels, this would dampen overall neuronal excitability in the brain and perhaps provide a new tool for treating epilepsy,” says Slesinger.

A research article describing the study has been published in the journal Nature Neuroscience. (ANI)

‘Singing brains’ offer hope for better epilepsy, schizophrenia treatments

Washington, May 20 (ANI): A team of scientists at Cardiff University, led by an Indian origin boffin, has discovered that studying the way a person’s brain ‘sings’ could shed light on conditions such as epilepsy and schizophrenia and help develop better treatments.

Professor Krish Singh of Cardiff University’s School of Psychology, who led the research, and his colleagues found that a person’s brain produces a unique electrical oscillation at a particular frequency when a person looks at a visual pattern.

They also found that the frequency of this oscillation appears to be determined by the concentration of a neurotransmitter chemical, GABA, in the visual cortex of each person’s brain.

The more GABA was present, the higher the frequency or “note” of the oscillation. GABA is a key inhibitory neurotransmitter and is essential for the normal operation of the brain.

“Using sophisticated MEG and MRI brain imaging equipment, we’ve found that when a person looks at a visual pattern their brain produces an electrical signal, known as a gamma oscillation, at a set frequency,” Sing said.

“In effect, each person’s brain ‘sings’ at a different note in the range 40-70 Hz. This is similar to the notes in the lowest octaves of a standard piano keyboard or the lower notes on a bass guitar. Importantly, we also found that this frequency appears to be controlled by how much of an essential neurotransmitter, GABA, is present in a person’s visual cortex,” he added.

According to the researchers, these findings will have important implications for future clinical studies, especially in terms of increasing our understanding of conditions such as epilepsy and schizophrenia, where it is known that there may be a problem with GABA.

” We hope that the study of gamma oscillation frequency will provide a new window into the action of neurotransmitters such as GABA and how their function is compromised in diseases such as epilepsy and schizophrenia,” Singh said.

“We also believe that our findings could have important implications for the development, production and effectiveness of drugs to treat these and other neurological conditions,” Singh added.

The study has been published in the Proceedings of the National Academy of Sciences, USA. (ANI)

Brain-scanning process may pave way for new epilepsy treatments

Washington, May 20 (ANI): A new brain-scanning process developed by a University of Minnesota researcher may pave the way for new treatments of epilepsy.

Developed by Bin He UM McKnight professor and Director of Centre for Neuroengineering, the technique has attained preliminary successes in noninvasive imaging of seizure foci, which promises to play an important role in the treatment of epileptic seizures.

The study, called Functional Neuroimaging, has completed its first round of testing in epilepsy data collected at the Mayo Clinic.

The medical device used in the procedure images the brain while epilepsy patients have a seizure, and then allows surgeons to identify the network where the seizure is caused.

Approximately one-third of people who suffer from epileptic seizures cannot be treated by medication.

Thus, this process could lead to further advancements in surgical treatment. (ANI)

Scientists identify promising compound to treat epilepsy

Washington, May 5 (ANI): Scientists have identified a new anticonvulsant compound, called paxilline, which may cease the progression of epilepsy, a neurological disorder marked by abnormal electrical activity in the brain that leads to recurring seizures.

The study by Carnegie Mellon University researchers is based on a previous work in which scientists identified a specific molecular target whose increased activity is linked with seizure disorders- a potassium channel known as the BK channel.
“We have found a new anticonvulsant compound that eliminates seizures in a model of epilepsy,” said Alison Barth, associate professor of biological sciences at Carnegie Mellon’s Mellon College of Science.

She added: “The drug works by inhibiting ion channels whose role in epilepsy was only recently discovered. Understanding how these channels work in seizure disorders, and being able to target them with a simple treatment, represents a significant advance in our ability to understand and treat epilepsy.” he researchers found that after a first seizure, BK channel function was markedly enhanced.

Thus, the neurons became overly excitable and were firing with more speed, intensity and spontaneity, which led the researchers to believe that the abnormal increase in the activity of the channels might play a role in causing subsequent seizures and the emergence of epilepsy. n the current study, the researchers tested this theory by blocking the ion channels using a BK-channel antagonist called paxilline.

Using an experimental model for epilepsy, Barth tested whether paxilline could reduce or prevent experimentally induced seizures, as it could normalize aberrant brain activity induced by previous seizures.

And to their surprise, the researchers discovered that the compound was effective at completely blocking subsequent seizures. The drug is orally available, and works in the low nanomolar range,” said Barth.

As the drug is effective in low concentrations and can be taken as a pill, it could turn out to be an especially promising compound for treatment in epilepsy patients.

The researchers believe that targeting the BK channels and the abnormal brain activity that they induce might one day be used as a way to prevent the progression of seizure disorders over time, thus attacking the root cause of epilepsy.

The findings have been published in the current issue of the journal Epilepsia. (ANI)

Anxiety drug can treat restless legs syndrome, improve sleep

Washington, Apr 30 (ANI): A drug, called pregabalin-commonly used to treat seizures and anxiety-has now been implicated as an effective treatment for restless legs syndrome (RLS), according to a study.

The 12-week study involved 58 people with RLS, out of which, 30 received the drug pregabalin and the rest received placebo.

The researchers performed sleep studies at the beginning and end of the research.

Almost two-thirds of the people who took pregabalin were found to have no RLS symptoms while taking the drug.

People who still had symptoms, reported of improvement in those symptoms by 66 percent while taking the drug, as compared to the placebo group where symptoms worsened by 29 percent.

In fact, improvement in sleep was also reported for those taking pregabalin.

The study showed the group spent more time in slow wave sleep, otherwise known as Stage 3 or deep sleep, and they spent less time in the lighter sleep stages known as Stage 1 or Stage 2 sleep compared to those taking placebo.

“Since RLS symptoms get worse at night, it’s difficult for people with RLS to get adequate sleep. However, our findings show pregabalin helped people get more deep sleep. The drug was well tolerated and is a promising alternative to current treatments because of its superior effects on quality of sleep,” said study author Diego Garcia-Borreguero, MD, Director of the Sleep Research Institute in Madrid, Spain.

Pregabalin has been approved for epilepsy, nerve pain, generalized anxiety and fibromyalgia.

The study will be presented as part of the Late-breaking Science Program at the American Academy of Neurology’s 61st Annual Meeting in Seattle. (ANI)

Prince reveals his childhood epilepsy ordeal

London, Apr 30 (ANI): American musician Prince Rogers Nelson has in an exclusive interview revealed the ordeal he went through while suffering from epilepsy.

Prince, 50, revealed to US talk show host Tavis Smiley that when he was “born epileptic” his parents had to struggle to cope with his fits.

“My mother and father didn’t know what to do or how to handle it but they did the best they could with what little they had,” the BBC quoted him as saying.

The singer said he was “teased a lot” at school, and also recalled how as a child he believed divine intervention had helped him overcome the illness.

“My mother told me one day I walked in to her and said, ‘Mum, I’m not going to be sick anymore’,” he said.

“She said ‘Why?’ and I said ‘Because an angel told me so.’ Now, I don’t remember saying it, that’s just what she told me,” he added.

He went on to reveal that before the seizures stopped he tried to “compensate” for the illness by being “as noisy as I could and be as flashy as I could”. (ANI)

Gene that switches on during epilepsy development identified

Washington, Apr 23 (ANI): Researchers at Wake Forest University School of Medicine have identified a gene that switches on during development of epilepsy.

The discovery made while studying mice may help explain how some people without a genetic predisposition to epilepsy can develop the disorder.

In a study published this month in the Journal of Neuroscience, senior researcher Dwayne W. Godwin, Ph.D., a professor of neurobiology and anatomy, and colleagues, report discovering that a gene, already known to predispose people who inherit an active form of it to certain forms of epilepsy, can actually be “switched on” in animals that do not appear to have inherited the active form, and therefore a genetic predisposition, to the condition.

The gene codes a calcium channel in the brain that underlies seizures, so the finding may reveal a mechanism by which epilepsy develops in those with no apparent genetic predisposition to it.

“Epilepsy is a terrible disorder that affects millions of kids and adults all over the world,” Godwin said.

“There are many different forms of epilepsy with different symptoms. We don’t know why some people acquire epilepsy – the cause isn’t always clear from the person’s genetic makeup. We do know that in some forms of epilepsy, once someone has a seizure they tend to have more. Our findings from this study suggest that something about the brain changes that can lead to this increased tendency to have a seizure. Our study shows that an important change occurs in calcium channels that help to transmit this abnormal activity throughout the brain,” the expert added.

Calcium channels come in a variety of forms throughout the body and are responsible for several key functions, depending on their placement and quantity. The calcium channels in the brain are normally embedded within the membrane of brain cells, where they allow passage of calcium ions into the cell and are responsible for the electrical activity of the brain.

The passage of calcium ions into cells determines how excitable the cells are, and how easily abnormal activity spreads through the brain.

If, as in epilepsy, a particular channel shows up where it is not supposed to or appears in too many or too few numbers, the function that channel is responsible for can become abnormal. Researchers know that during epileptic seizures, these calcium channels in the brain, responsible for generating electrical brain rhythms, become highly active.

For the study, researchers used a mouse model to observe changes in tissue from regions of the brain that are involved in seizures, the hippocampus and the thalamus. They measured these changes at different time intervals as the mice developed epilepsy. The researchers found that after an initial seizure, more of this particular kind of calcium channel begins to be expressed where it wasn’t before, and the presence of the channel caused brain activity to become increasingly abnormal and epileptic.

“Calcium channels underlie valuable functions. But in the wrong place, at the wrong time, or in the wrong amount, their presence can be disruptive. In the context of brain circuits, the brain cells that have too many copies of the channel get over excited and respond abnormally,” Godwin said.

While the hippocampus is usually targeted in studies of epilepsy, the new channels were being made in a region of the brain called the thalamus. The thalamus is connected to the hippocampus and is involved in the spread of seizures throughout the brain.

“Certain kinds of channels are normal and expected in the thalamus, but after an initial seizure more copies of a channel that isn’t normally found in this brain region begin to appear,” explained graduate student John Graef, the first author on the study.

“The brain activity then becomes dominated by the new copies of this channel. It helps explain how seizures can develop and spread,” the expert added. (ANI)

Cognitive therapy can ease nonepileptic seizures

Washington, April 16 (ANI): Cognitive behavioral therapy (CBT) can benefit patients with psychogenic nonepileptic seizures (PNES), according to a new study.

PNES is a condition that is marked by seizures resembling epileptic seizures. However, unlike epilepsy, seizures in patients with PNES are not caused by the same brain cell firing that occurs with epilepsy.

Patients who suffer from PNES often exhibit a higher incidence of symptoms such as anxiety and depression than patients with epilepsy, along with a reduced quality of life due to the effect of the seizures themselves.

However, it is recognized that conditions such as anxiety and depression often respond well to CBT.

Keeping that in mind, senior author W. Curt LaFrance, Jr., MD, MPH, director of the division of neuropsychiatry and behavioral neurology at Rhode Island Hospital, developed a CBT for PNES treatment manual.

Modified from a CBT for patients with epilepsy workbook, the treatment manual has been developed over the past five years to address core issues in patients with PNES.

LaFrance, who is also an assistant professor of psychiatry and neurology (research) at the Warren Alpert Medical School of Brown University, worked with colleagues at Rhode Island Hospital’s comprehensive epilepsy center to conduct an open, prospective clinical trial assessing the outcomes of outpatients with video-electroencephalogram (EEG)-confirmed PNES who were treated using the CBT for PNES manual.

The researchers outlined a clinical model for management of PNES, where a key component is to identify precursors, precipitants and perpetuating factors of the seizures.

“Based on the tendency of patients with PNES to somatize (to manifest mental pain as pain in one’s body), we hypothesized that identifying and modifying cognitive distortions and environmental triggers for PNES would reduce PNES,” LaFrance said.

The researchers then identified patients who were referred to the Rhode Island Hospital neuropsychiatry/behavioral neurology clinic after being diagnosed with PNES and at least one typical PNES was captured on video EEG.

Of the 101 patients who were assessed for eligibility, 21 patients met the criteria or agreed to participate. Of those 21, 17 completed the 12-week session of CBT intervention and were included in the analysis.

LaFrance noted that the results of the clinical trial showed the CBT to be effective in terms of reducing the frequency of PNES.

The evaluation of quality of life scores, as well as assessments of depression, anxiety, somatic symptoms and psychosocial functioning also showed statistically significant improvement from baseline to final session.

The study was published in the April 2009 edition of Epilepsy and Behavior. (ANI)

NEWSWEEK Cover: The Mystery of Epilepsy

Why We Must Find a Cure for Epilepsy

The Toll of Epilepsy Has Been Overlooked – and the Research Underfunded -For
Too Long

NEW YORK, April 12 /PRNewswire/ — “Put harshly, we need more of a cancerlike
sensibility around epilepsy,” Newsweek Editor Jon Meachamwrites in the April
20 cover, “The Mystery of Epilepsy” (on newsstands Monday, April 13). “We
cannot usually see our friends’ cancer, but we do not hesitate to invest the
search for a cure for different cancers with the utmost cultural and political
importance. We must now do the same with epilepsy.” Meacham writes that the
toll of epilepsy has been overlooked — and the research underfunded — for
too long. Public and private funding for research lag far behind other
neurological afflictions. “It is time to remedy that gap, and to raise
epilepsy to the front ranks of public and medical concern,” he writes.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090412/NY97676 )

“Epilepsy in America is as common as breast cancer, and takes as many lives,”
Meacham writes. A mysterious and widely misunderstood affliction, epilepsy is
a disorder in which the brain produces sudden bursts of electrical energy that
can interfere with a person’s consciousness, movements or sensations. By some
estimates, the mortality rate for people with epilepsy is two to three times
higher — and the risk of sudden death is 24 times greater — than that of the
general population. Yet epilepsy still receives too little attention, either
from the medical community or the public at large. “One reason is that
advances in drug treatments have created the popular impression that epilepsy
is now an essentially manageable condition,” Meacham writes. “Most people
with epilepsy are not in a constant state of seizure — they are, rather, in
perpetual but quiet danger — their condition can appear less serious than it
truly is. It is all too human, but all too true, that a problem, including the
problem of a serious medical affliction, stays out of mind when it is out of
sight.”

Also in the cover package, SeniorEditor Jerry Adler and Contributor Eliza Gray
profile a doctor on the front lines of the epilepsy wars, Orrin Devinsky of
New York University. Devinsky tries to find the right combinations of drugs
to help his patients. Adler and Gray write, “There are, at this time, only a
few ways to treat epilepsy, and applying them is still an art as much as it is
a science. What works for one patient often has no benefit for another with
identical symptoms.”

Susan Axelrod, who is married to David Axelrod, President Obama’s senior
adviser, and is a founding board member and president of CURE, Citizens United
for Research in Epilepsy, contributes an essay on her family’s experience with
epilepsy — and what it has led her to believe must be done. The Axelrods’
daughter, Lauren, suffered her first seizure when she was just 7 months old.
“Epilepsy entered our lives more than 25 years ago, and yet, far too often, I
have no confidence that outcomes today will be any better than they were for
Lauren,” she writes.

(Read cover at www.Newsweek.com)

Cover: http://www.newsweek.com/id/193586
In the Grip of the Unknown: http://www.newsweek.com/id/193484
Agony, Hope and Resolve: http://www.newsweek.com/id/193587

SOURCE Newsweek

Katherine Barna of Newsweek, +1-212-445-4859